BAC
Bank of America Corporation
BAC has the edge over NECB overall, supported by stronger fundamentals and stronger valuation.
NECB
Northeast Community Bancorp, Inc.
NECB's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
NECB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
NECB's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like NECB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over NECB in the historical PE scenario, which offers more potential upside but is not a forecast.
NECB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $18.52 | -36% |
| Forward | 7.4x | $29.07 | — |
| Fair | 7.5x | $22.77 | -22% |
| Current | 9.6x | $29.07 | — |
| Expensive | 13x | $39.16 | +35% |
Historical ranges are pointers, not guarantees.
NECB's PE is in its expensive range at 9.6x. If earnings grow as analysts expect, today's price would be 7.4x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
NECB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NECB, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over NECB on earnings, with more consistent year-over-year improvement.
NECB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.94 | +30% |
| Q3 2026 | $3.03 | -5.6% |
| Q2 2026 | $3.11 | -5.5% |
| Q1 2026 | $3.21 | -6.7% |
| Q4 2025 | $3.25 | -7.7% |
| Q3 2025 | $3.21 | -15% |
| Q2 2025 | $3.29 | -9.4% |
| Q1 2025 | $3.44 | +0.9% |
| Q4 2024 | $3.52 | +6% |
NECB earned $3.03 per share over the past year, down 5.6% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over NECB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
NECB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26.1M | -3.2% |
| Q2 2026 | $25.3M | -2.5% |
| Q1 2026 | $24.9M | -2.2% |
| Q4 2025 | $26.4M | +3.9% |
| Q3 2025 | $27M | -2.5% |
| Q2 2025 | $25.9M | -3.8% |
| Q1 2025 | $25.5M | -0.2% |
| Q4 2024 | $25.4M | -4.3% |
NECB's revenue grew through 2023 and has held roughly level since: $26M last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 58% | -3.5 points |
| Q2 2026 | 55% | -4.9 points |
| Q1 2026 | 56% | -1.1 points |
| Q4 2025 | 59% | +2 points |
| Q3 2025 | 62% | -2 points |
| Q2 2025 | 59% | -6.1 points |
| Q1 2025 | 57% | -5.3 points |
| Q4 2024 | 57% | -7.5 points |
NECB has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over NECB on cash flow, with more consistent year-over-year improvement.
NECB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11M | -19% |
| Q2 2026 | $12.7M | -15% |
| Q1 2026 | $10.3M | -2.1% |
| Q4 2025 | $11.8M | +17% |
| Q3 2025 | $13.6M | -4.5% |
| Q2 2025 | $14.9M | +35% |
| Q1 2025 | $10.6M | -18% |
| Q4 2024 | $10.1M | -14% |
NECB's free cash flow was $46M over the past year, down 6.8% from the year before. Free cash flow isn't a meaningful measure for financial services companies like NECB.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over NECB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
NECB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +28K shares |
| 1 year | -0.5% | -66K shares |
| 3 years | -8.5% | -1.3M shares |
| 5 years | -17% | -2.8M shares |
NECB has 14M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $168,000 |
| Q2 2026 | $1.1M |
| Q1 2026 | $3.6M |
| Q4 2025 | $1.4M |
| Q4 2024 | $726,000 |
| Q3 2024 | — |
| Q2 2024 | $1.2M |
| Q1 2024 | $1.3M |
NECB spent $6M buying back its own shares over the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
NECB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | -1.4x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
| Q2 2024 | -1.0x | Net Cash |
NECB has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
NECB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.8 | Neutral |
| Stochastic | 76.8 | Neutral |
NECB's weekly RSI is 70 (neutral) and its Stochastic is 77 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
NECB PE vs Financial Services Sector
| Metric | NECB | Sector median | Relative |
|---|---|---|---|
| PE | 9.6x | 13x | 26% below |
| PE % | 69 | 63 | 6 pts above |
NECB has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
NECB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.9 | 4.4% above |
| 20 week MA | $27.2 | 6.8% above |
| 50 week MA | $25.3 | 15% above |
| 100 week MA | $23.9 | 22% above |
| 200 week MA | $20.8 | 40% above |
NECB has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
NECB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.80 | $10.3 | +17% |
| 2021 | $10.3 | $11.2 | +8.8% |
| 2022 | $11.2 | $15.0 | +35% |
| 2023 | $15.0 | $17.7 | +18% |
| 2024 | $17.7 | $24.8 | +40% |
| 2025 | $24.8 | $23.0 | -7.3% |
| 2026 YTD | $23.0 | $29.1 | +27% |
NECB has the edge over BAC on returns for 2026, with the stronger performance.